[go: up one dir, main page]

AR057526A1 - Metodos para la produccion de composiciones oftalmicas oxidativamente estables - Google Patents

Metodos para la produccion de composiciones oftalmicas oxidativamente estables

Info

Publication number
AR057526A1
AR057526A1 ARP060104336A ARP060104336A AR057526A1 AR 057526 A1 AR057526 A1 AR 057526A1 AR P060104336 A ARP060104336 A AR P060104336A AR P060104336 A ARP060104336 A AR P060104336A AR 057526 A1 AR057526 A1 AR 057526A1
Authority
AR
Argentina
Prior art keywords
production
methods
ophthalmic compositions
oxidatively stable
stable ophthalmic
Prior art date
Application number
ARP060104336A
Other languages
English (en)
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of AR057526A1 publication Critical patent/AR057526A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0005—Degasification of liquids with one or more auxiliary substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0036—Flash degasification
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0073—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0073—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042
    • B01D19/0078—Degasification of liquids by a method not covered by groups B01D19/0005 - B01D19/0042 by vibration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D7/00—Sublimation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D7/00—Sublimation
    • B01D7/02—Crystallisation directly from the vapour phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se relaciona con un proceso para mejorar la estabilidad de una solucion compatible para uso oftalmologico que comprende por lo menos un compuesto oftálmico oxidativamente inestable. Reivindicacion 1: Un proceso que comprende la remocion de por lo menos 80% del oxígeno de una solucion compatible para uso oftalmologico que comprende por lo menos un compuesto oftálmico oxidativamente inestable.
ARP060104336A 2005-09-30 2006-10-02 Metodos para la produccion de composiciones oftalmicas oxidativamente estables AR057526A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/241,313 US20070077303A1 (en) 2005-09-30 2005-09-30 Methods for providing oxidatively stable ophthalmic compositions

Publications (1)

Publication Number Publication Date
AR057526A1 true AR057526A1 (es) 2007-12-05

Family

ID=37619526

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104336A AR057526A1 (es) 2005-09-30 2006-10-02 Metodos para la produccion de composiciones oftalmicas oxidativamente estables

Country Status (11)

Country Link
US (2) US20070077303A1 (es)
EP (1) EP1769834A3 (es)
JP (1) JP2007099768A (es)
KR (1) KR20070037415A (es)
CN (1) CN1939278A (es)
AR (1) AR057526A1 (es)
AU (1) AU2006225174B2 (es)
BR (1) BRPI0604723A (es)
CA (1) CA2561676A1 (es)
SG (1) SG131101A1 (es)
TW (1) TW200730468A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101420934B (zh) 2006-03-17 2014-03-19 庄臣及庄臣视力保护公司 用于使氧化不稳定的组合物稳定的方法
ES2594655T3 (es) 2006-03-31 2016-12-21 Vistakon Pharmaceuticals, Llc Tratamiento de alergias oculares
WO2008151019A1 (en) * 2007-05-30 2008-12-11 University Of Florida Research Foundation, Inc. Extended release of bioactive molecules from silicone hydrogels
AU2010325632B2 (en) * 2009-12-03 2014-01-30 Lupin Limited Process for preparing pharmaceutical ophthalmic compositions
WO2013033337A1 (en) * 2011-08-31 2013-03-07 Johnson & Johnson Vision Care, Inc. Liquid meniscus lens with improved saline formulation
KR101703980B1 (ko) * 2013-12-30 2017-02-08 주식회사 삼양바이오팜 항산화제를 함유하지 않는 약학 조성물 및 그의 제조방법
KR101919436B1 (ko) * 2015-05-28 2018-11-16 주식회사 삼양바이오팜 안정화된 약학 조성물 및 그의 제조방법
GR1008942B (el) * 2015-10-14 2017-02-06 ΙΟΥΛΙΑ ΚΑΙ ΕΙΡΗΝΗ ΤΣΕΤΗ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "INTERMED ΑΒΕΕ" Μεθοδος παραγωγης σταθερου υδατικου διαλυματος λυσινικης ιμπουπροφαινης για ενδοκολπικη χρηση
CN108686252B (zh) * 2018-06-11 2021-05-18 深圳英凡妮生物科技有限公司 一种以壳聚糖-泊洛沙姆为基质的纳米银抗菌敷料及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639576A (en) * 1968-06-19 1972-02-01 Barnes Hind Pharm Inc Resterilizing contact lens solution
BE901885A (fr) * 1985-03-06 1985-07-01 Bruschettini Srl Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation.
US4931225A (en) * 1987-12-30 1990-06-05 Union Carbide Industrial Gases Technology Corporation Method and apparatus for dispersing a gas into a liquid
US4853088A (en) * 1988-04-12 1989-08-01 Marathon Oil Company Solar enhanced separation of volatile components from a liquid
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
IT1258781B (it) * 1992-01-16 1996-02-29 Zambon Spa Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
JPH07286027A (ja) * 1994-04-19 1995-10-31 Hoya Corp 眼装着用レンズ材料及びそれを用いた眼装着用レンズ
US5597519A (en) * 1994-06-10 1997-01-28 Johnson & Johnson Vision Products, Inc. Ultraviolet cycling oven for polymerization of contact lenses
US5922249A (en) * 1995-12-08 1999-07-13 Novartis Ag Ophthalmic lens production process
JP3689900B2 (ja) * 1998-08-19 2005-08-31 ニプロ株式会社 医療用成形品
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US20020037897A1 (en) * 2000-08-07 2002-03-28 3-Dimensional Pharmaceuticals, Inc. Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
WO2002100436A2 (en) * 2001-06-08 2002-12-19 Novartis Ag Ophthalmic once-a-day composition
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
US20060100408A1 (en) * 2002-03-11 2006-05-11 Powell P M Method for forming contact lenses comprising therapeutic agents
DE20217473U1 (de) * 2002-11-11 2003-03-27 Analysen Service GmbH Umwelt- und Öllabor Leipzig, 04277 Leipzig Entgasungsmodul für Fluidproben
JP2005124809A (ja) * 2003-10-23 2005-05-19 Sanyo Chem Ind Ltd 医療用接着剤
FR2894154B1 (fr) * 2005-12-06 2008-03-14 Pharmatop Scr Nouveau procede de stabilisation de substances minerales ou organiques sensibles a l'oxydation.

Also Published As

Publication number Publication date
SG131101A1 (en) 2007-04-26
TW200730468A (en) 2007-08-16
AU2006225174A1 (en) 2007-04-19
JP2007099768A (ja) 2007-04-19
EP1769834A2 (en) 2007-04-04
BRPI0604723A (pt) 2007-08-28
AU2006225174B2 (en) 2012-07-05
EP1769834A3 (en) 2009-10-07
CN1939278A (zh) 2007-04-04
US20110201596A1 (en) 2011-08-18
CA2561676A1 (en) 2007-03-30
KR20070037415A (ko) 2007-04-04
US20070077303A1 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
MA33275B1 (fr) Inhibiteurs de la replication du virus de l'immunodeficience humaine
DOP2006000170A (es) Nuevos derivados de espirocromanona
ECSP078060A (es) 2,4-diamino-pirimidinas como inhibidores de aurora
UY30444A1 (es) Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.
MX2014008773A (es) Composiciones y metodos para el uso de ésteres de forbol.
NI200700064A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3- trifluorometil-fenil)- ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos.
UY32072A (es) Tienopirimidinas para composiciones farmacéuticas
UY32259A (es) Nuevos compuestos de hidroxiareno, preparados farmaceuticos que los contienen y aplicaciones
CR10479A (es) Modulares bencimidazolicos de vr1
ECSP088099A (es) Nuevos derivados de la 2-azetidinona para el tratamiento de enfermedades hiperlipidémicas
MA35749B1 (fr) Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc
CR9463A (es) Pirrolinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
NI200500164A (es) Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas, correspondiente metodo de produccion, medicamentos que contienen dicho compuesto y su uso.
IS8505A (is) (S)-2-N-própýlamínó-5-hýdroxýetralín sem D3-gerandefni
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
BRPI0412999A (pt) 2-aminotetralina substituìda para tratamento de depressão
GT200600086A (es) Forma cristalina de gamma-d del clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmacéuticas que la contienen
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
AR057526A1 (es) Metodos para la produccion de composiciones oftalmicas oxidativamente estables
AR064658A1 (es) Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
PL1758852T3 (pl) Podstawione związki cyklopentenu
AR071721A1 (es) Derivados de piridil-prolinamida, composiciones farmaceuticas que los contienen y su uso para el tratamiento de ansiedad, depresion y trastornos del sueno.
ECSP066770A (es) Nuevos ésteres de quinuclidina cuaternizados
CL2011003123A1 (es) Compuestos derivados de ciclopentanamida sustituidos; composicion farmaceutica; proceso de obtencion; y uso en el tratamiento o la profilaxis de la diabetes, aterosclerosis, entre otras.
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents

Legal Events

Date Code Title Description
FA Abandonment or withdrawal